[go: up one dir, main page]

HK1158981B - 高濃度抗體和蛋白製劑 - Google Patents

高濃度抗體和蛋白製劑 Download PDF

Info

Publication number
HK1158981B
HK1158981B HK11113741.2A HK11113741A HK1158981B HK 1158981 B HK1158981 B HK 1158981B HK 11113741 A HK11113741 A HK 11113741A HK 1158981 B HK1158981 B HK 1158981B
Authority
HK
Hong Kong
Prior art keywords
antibody
formulation
cells
protein
antibodies
Prior art date
Application number
HK11113741.2A
Other languages
German (de)
English (en)
French (fr)
Other versions
HK1158981A (zh
Inventor
Jun Liu
Steven Shire
Original Assignee
Genentech, Inc.
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech, Inc., Novartis Ag filed Critical Genentech, Inc.
Publication of HK1158981A publication Critical patent/HK1158981A/zh
Publication of HK1158981B publication Critical patent/HK1158981B/zh

Links

HK11113741.2A 2003-04-04 2011-12-20 高濃度抗體和蛋白製劑 HK1158981B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US460659P 2003-04-04

Publications (2)

Publication Number Publication Date
HK1158981A HK1158981A (zh) 2012-07-27
HK1158981B true HK1158981B (zh) 2018-01-12

Family

ID=

Similar Documents

Publication Publication Date Title
EP2335725B1 (en) High concentration antibody and protein formulations
US20050158303A1 (en) Methods of treating IgE-mediated disorders comprising the administration of high concentration anti-IgE antibody formulations
AU2012200957B2 (en) High concentration antibody and protein formulations
HK1158981B (zh) 高濃度抗體和蛋白製劑
HK1085933B (zh) 高濃度抗體和蛋白製劑
HK1158981A (zh) 高濃度抗體和蛋白製劑
HK1164151A (zh) 高浓度抗体和蛋白制剂